Arcadia Biosciences (RKDA) Misses Q1 EPS by 3c

Arcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.02 million versus the consensus estimate of $1.2 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Tech eyes recovery after selloff, Micron to report results - What’s moving markets
• Cerebras Q1 EPS miss sends shares down 9% after-hours